Collectively, these findings highlight the distinct and context-dependent roles of ROCK1 and ROCK2 in pulmonary hypertension, cardiac remodeling, fibrosis, and atherosclerosis, underscoring their potential as differential therapeutic targets in cardiovascular diseases. The gene discussed is ROCK2; the disease is atherosclerosis.